CoChat

Intranasal versus injectable glucagon for hypoglycemia in type 1 diabetes: systematic review and meta-analysis

Pontiroli, Antonio E., Tagliabue, Elena · 2020 · Acta Diabetologica

The DOI matches its Crossref record; 48 of the 50 references it cites were found in a registry or an index.

Abstract

Aims Glucagon is used to resolve severe hypoglycemia in unconscious patients with diabetes, requiring third-party assistance. A few studies have shown that intranasal (IN) glucagon causes resolution of hypoglycemia in insulin-treated patients with type 1 (T1DM) diabetes. This systematic review and meta-analysis updates the comparison of the effectiveness of IN glucagon with injected intramuscular/subcutaneous (IM/SC) glucagon in treatment of hypoglycemia in T1DM. Methods Controlled randomized studies were considered; eight studies, published in English, were included in a meta-analysis (random-effects model). Intervention effect (resolution of hypoglycemia) was expressed as odds ratio (OR), with 95% confidence intervals. Meta-regression was employed to correlate the effect with size of studies, age of patients, basal blood glucose levels. Results In a total of 467 treatments in 269 patients with IN and IM/SC glucagon, the OR IN versus IM/SC was 0.61 (CI 0.13-2.82); since four of eight studies showed 100% effectiveness, a simulation was made with 1 failure for each treatment; in this simulation analysis, the OR was 0.80 (95% CI 0.28-2.32). Heterogeneity was low and not statistically significant. Publication bias was absent, and quality of papers was high. At meta-regression, no correlation was found between the effect and number of patients in each study, age of patients, basal blood glucose levels. No study formally compared IN versus IM/SC in unconscious patients. Conclusion…

Overview

Integrity signals

Registry

Crossref · 10.1007/s00592-020-01483-y

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 48 references

Research works printed but not linked: 1

  1. Centers for Disease Control and Prevention (CDC) (2011) National diabetes fact sheet: national estimates, general information on diabetes, prediabetes in the United States. US Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta

Cited by

See all 25

Metadata

Authors
Pontiroli, A. E., & Tagliabue, E.
Affiliations
  • University of Milan (IT)
  • MultiMedica (IT)
Corresponding author
Pontiroli, Antonio E.
Venue
Acta Diabetologica
Published
2020-02-06
Volume
57
Issue
6
Pages
743-749
ISSN
  • 0940-5429 (ISSN-L)
  • 1432-5233
OpenAlex
W3004952652
Cited by
25
References
50
Citations by year
2025: 2 · 2024: 5 · 2023: 5 · 2022: 9 · 2021: 4
FWCI
0.69
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Acta Diabetologica (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Ministero della Salute (ricerca corrente)
  • Università degli Studi di Milano (not applicable)
  • gruppo Multimedica (not applicable)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Patient Safety and Medication Errors
Keywords
hypoglycemia, type 1 diabetes, severe hypoglycemia, unconscious patients, third-party assistance
MeSH terms
Administration, Intranasal, Blood Glucose, Diabetes Mellitus, Type 1, Glucagon, Humans, Hypoglycemia, Injections, Intramuscular, Injections, Subcutaneous, Insulin, Randomized Controlled Trials as Topic, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Intranasal versus injectable glucagon for hypoglycemia in type 1 diabetes: systematic review and meta-analysis. https://app.cochat.ai/papers/10.1007/s00592-020-01483-y
The paper
Pontiroli, A. E., & Tagliabue, E. (2020). Intranasal versus injectable glucagon for hypoglycemia in type 1 diabetes: systematic review and meta-analysis. Acta Diabetologica. https://doi.org/10.1007/s00592-020-01483-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.